Axsome Therapeutics, Inc. (AXSM)
Axsome Therapeutics, Inc. (AXSM) is a Healthcare stock tracked by StreetAlpha. AXSM reports earnings on Mon, Nov 2, 2026. Analyst consensus is Strong Buy, based on the latest ratings from 11 firms (10 buy, 1 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in AXSM, 0% of them bullish and 100% bearish. In the past 30 days there were 1 dark pool print.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 8 | RBC Capital | Target lowered | Buy | — |
| Sep 29 | Deutsche Bank | Maintained | Buy | — |
| Sep 25 | Morgan Stanley | Target lowered | Hold | — |
| Sep 23 | Truist Securities | Maintained | Buy | — |
| Sep 18 | Piper Sandler | Reiterated | Buy | — |
Whale Options Flow
90DDark Pool
30DAI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AXSM is in one of them and how their past AXSM trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered AXSM in an article yet. Here's the latest on the wider market.